Biote (BTMD) Tariff Resilience Score: 6/10 (As of Jul. 02, 2026)


BTMD Biote Corp BTMD
66 GF Score
Price $2.18
GF Value $3.07
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Biote Tariff Resilience Score?

Biote BTMD +7.96% 66 Tariff Resilience Score is 6 as of Jul. 02, 2026. GuruFocus rates BTMD with a GF Score™ of 66/100 and a GF Value™ of $3.07 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 675 Healthcare Providers & Services companies, Biote ranks better than 83.56% on this metric.

Biote has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Biote has Healthcare sector with some exposure to international supply chains. Manufacturing is localized, but some components are imported. Historical tariffs have had moderate impact. Mitigation through alternative suppliers is possible.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Biote might have Average Resilient.

Biote  (NAS:BTMD) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Biote Tariff Resilience Score Related Terms

BTMD vs DCGO, PIII, EHSI: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Biote's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biote Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Biote's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Biote's Tariff Resilience Score falls into.


BTMD
66GF Score
Biote Corp BTMD
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Biote (BTMD) has a Tariff Resilience Score of 6 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Biote ranks #111 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is Biote's Tariff Resilience Score too high?
Biote's current Tariff Resilience Score is 6. Based on the distribution chart, Biote ranks #111 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Biote has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biote's Tariff Resilience Score compare to DCGO and PIII?
According to the Healthcare Providers & Services industry distribution chart, Biote ranks #111 out of 675 companies for Tariff Resilience Score. This places Biote in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Biote's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biote stock overvalued right now?
Based on GuruFocus' analysis, Biote (BTMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.07, compared to a current price of $2.18 — trading 29% below its estimated fair value. The current Tariff Resilience Score is 6. Biote's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Biote (BTMD), the current Tariff Resilience Score is 6 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biote (BTMD) Overvalued in 2026?

Based on GuruFocus' analysis, Biote stock appears to be undervalued. The current stock price of $2.18 is trading 29% below its estimated GF Value™ of $3.07. GuruFocus considers Biote to be Modestly Undervalued.

Key valuation signals for BTMD:

  • Tariff Resilience Score: 6
  • GF Value™: $3.07 vs. price of $2.18 (29% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the BTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biote Business Description

Address 1875 W. Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
66GF Score

Get the complete analysis for BTMD

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.18
Price
$3.07
GF Value